University of Michigan

Millendo Therapeutics, Inc

Atterocor, Inc.

Gary Hammer

Tom K Kerppola

Raili Kerppola

Dipika Mohan

Antonio M Lerario

Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment of adrenocortical carcinoma (ACC), Cushing's syndrome and/or pituitary ACTH excess (Cushing's Disease). Such methods involve administration of an effective amount N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethyl amino)phenyl)cyclopentyl)-methyl)urea hydrochloride to the patient.

Compounds and methods for treating aberrant adrenocortical cell disorders

Methods and compositions are provided for treatment of disorders associated with aberrant adrenal cortex cell behavior, including (but not limited to) treatment of adrenocortical carcinoma (ACC), Cushing's syndrome and/or pituitary ACTH excess (Cushing's Disease). Such methods involve administration of an effective amount N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)-methyl)urea hydrochloride to the patient.

Compounds and methods for treating aberrant adrenocartical cell disorders

Growing community of inventors

Ann Arbor, MI, United States of America

Gary Hammer